Return On Equity in % of GUIDED THERAPEUTICS INC from Q3 2012 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
GUIDED THERAPEUTICS INC quarterly/annual Return On Equity history and change rate from Q3 2012 to Q3 2025.
  • GUIDED THERAPEUTICS INC Return On Equity for the quarter ending 30 Sep 2025 was 49.4 %.
  • GUIDED THERAPEUTICS INC annual Return On Equity for 2021 was 34.8 %, a 1536% increase from 2020.
  • GUIDED THERAPEUTICS INC annual Return On Equity for 2020 was 2.13 %, a 80.7% decline from 2019.
  • GUIDED THERAPEUTICS INC annual Return On Equity for 2019 was 11.1 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

GUIDED THERAPEUTICS INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 49.4 01 Jul 2025 30 Sep 2025
Q3 2022 66.3 +75.8 01 Jul 2022 30 Sep 2022
Q2 2022 36.7 +60 01 Apr 2022 30 Jun 2022
Q1 2022 39.6 +10.8 +37.6% 01 Jan 2022 31 Mar 2022
Q4 2021 34.8 +32.7 +1536% 01 Oct 2021 31 Dec 2021
Q3 2021 -9.59 -19 -202% 01 Jul 2021 30 Sep 2021
Q2 2021 -23.3 -42.9 -218% 01 Apr 2021 30 Jun 2021
Q1 2021 28.8 +35.1 01 Jan 2021 31 Mar 2021
Q4 2020 2.13 -8.92 -80.7% 01 Oct 2020 31 Dec 2020
Q3 2020 9.43 -24.2 -71.9% 01 Jul 2020 30 Sep 2020
Q2 2020 19.6 -19.8 -50.2% 01 Apr 2020 30 Jun 2020
Q1 2020 -6.3 -8.17 -438% 01 Jan 2020 31 Mar 2020
Q4 2019 11.1 +17.6 01 Oct 2019 31 Dec 2019
Q3 2019 33.6 +12.9 +62.4% 01 Jul 2019 30 Sep 2019
Q2 2019 39.4 +8.02 +25.5% 01 Apr 2019 30 Jun 2019
Q1 2019 1.87 -61.5 -97.1% 01 Jan 2019 31 Mar 2019
Q4 2018 -6.54 -90.2 -108% 01 Oct 2018 31 Dec 2018
Q3 2018 20.7 -33.5 -61.8% 01 Jul 2018 30 Sep 2018
Q2 2018 31.4 -6.4 -16.9% 01 Apr 2018 30 Jun 2018
Q1 2018 63.4 +12 +23.3% 01 Jan 2018 31 Mar 2018
Q4 2017 83.7 +29.2 +53.6% 01 Oct 2017 31 Dec 2017
Q3 2017 54.2 -4.29 -7.34% 01 Jul 2017 30 Sep 2017
Q2 2017 37.8 -67.6 -64.1% 01 Apr 2017 30 Jun 2017
Q1 2017 51.4 -76.9 -60% 01 Jan 2017 31 Mar 2017
Q4 2016 54.5 -110 -66.9% 01 Oct 2016 31 Dec 2016
Q3 2016 58.5 -154 -72.5% 01 Jul 2016 30 Sep 2016
Q2 2016 105 -120 -53.3% 01 Apr 2016 30 Jun 2016
Q1 2016 128 -112 -46.6% 01 Jan 2016 31 Mar 2016
Q4 2015 164 -160 -49.4% 01 Oct 2015 31 Dec 2015
Q3 2015 212 -243 -53.4% 01 Jul 2015 30 Sep 2015
Q2 2015 226 -654 -74.3% 01 Apr 2015 30 Jun 2015
Q1 2015 240 +3.37K 01 Jan 2015 31 Mar 2015
Q4 2014 325 +1.04K 01 Oct 2014 31 Dec 2014
Q3 2014 455 +926 01 Jul 2014 30 Sep 2014
Q2 2014 880 +1.21K 01 Apr 2014 30 Jun 2014
Q1 2014 -3.13K -2.75K -742% 01 Jan 2014 31 Mar 2014
Q4 2013 -717 -339 -89.6% 01 Oct 2013 31 Dec 2013
Q3 2013 -470 -0.71 -0.15% 01 Jul 2013 30 Sep 2013
Q2 2013 -334 01 Apr 2013 30 Jun 2013
Q1 2013 -371 01 Jan 2013 31 Mar 2013
Q4 2012 -378 01 Oct 2012 31 Dec 2012
Q3 2012 -470 01 Jul 2012 30 Sep 2012

GUIDED THERAPEUTICS INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2021 34.8 +32.7 +1536% 01 Jan 2021 31 Dec 2021
2020 2.13 -8.92 -80.7% 01 Jan 2020 31 Dec 2020
2019 11.1 +17.6 01 Jan 2019 31 Dec 2019
2018 -6.54 -90.2 -108% 01 Jan 2018 31 Dec 2018
2017 83.7 +29.2 +53.6% 01 Jan 2017 31 Dec 2017
2016 54.5 -110 -66.9% 01 Jan 2016 31 Dec 2016
2015 164 -160 -49.4% 01 Jan 2015 31 Dec 2015
2014 325 +1.04K 01 Jan 2014 31 Dec 2014
2013 -717 -339 -89.6% 01 Jan 2013 31 Dec 2013
2012 -378 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.